Charles Schwab’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.13M Buy
664,543
+55,908
+9% +$684K ﹤0.01% 2114
2025
Q1
$8.72M Buy
608,635
+148,619
+32% +$2.13M ﹤0.01% 2015
2024
Q4
$7.32M Sell
460,016
-63,478
-12% -$1.01M ﹤0.01% 2152
2024
Q3
$12.6M Sell
523,494
-44,734
-8% -$1.07M ﹤0.01% 1923
2024
Q2
$11.3M Sell
568,228
-44,885
-7% -$894K ﹤0.01% 1983
2024
Q1
$12.2M Buy
613,113
+49,959
+9% +$995K ﹤0.01% 1889
2023
Q4
$12.6M Sell
563,154
-7,288
-1% -$163K ﹤0.01% 1865
2023
Q3
$11.5M Buy
570,442
+34,825
+7% +$704K ﹤0.01% 1837
2023
Q2
$13.7M Sell
535,617
-126,246
-19% -$3.23M ﹤0.01% 1745
2023
Q1
$19.7M Sell
661,863
-5,903
-0.9% -$176K 0.01% 1486
2022
Q4
$18.1M Buy
667,766
+16,700
+3% +$452K 0.01% 1512
2022
Q3
$14.2M Buy
651,066
+46,196
+8% +$1.01M 0.01% 1617
2022
Q2
$16.5M Buy
604,870
+48,842
+9% +$1.34M 0.01% 1543
2022
Q1
$18.6M Buy
556,028
+122,601
+28% +$4.11M 0.01% 1604
2021
Q4
$15M Buy
433,427
+19,342
+5% +$671K ﹤0.01% 1774
2021
Q3
$12.9M Buy
414,085
+7,342
+2% +$229K ﹤0.01% 1863
2021
Q2
$14.8M Buy
406,743
+9,483
+2% +$345K ﹤0.01% 1781
2021
Q1
$17.4M Buy
397,260
+3,636
+0.9% +$159K 0.01% 1633
2020
Q4
$18.1M Sell
393,624
-5,088
-1% -$233K 0.01% 1479
2020
Q3
$13.2M Sell
398,712
-11,898
-3% -$395K 0.01% 1488
2020
Q2
$12.1M Sell
410,610
-5,782
-1% -$170K 0.01% 1521
2020
Q1
$11.2M Buy
416,392
+24,619
+6% +$663K 0.01% 1381
2019
Q4
$13.2M Buy
391,773
+4,531
+1% +$153K 0.01% 1496
2019
Q3
$14.5M Buy
387,242
+17,490
+5% +$655K 0.01% 1355
2019
Q2
$16.1M Sell
369,752
-2,355
-0.6% -$103K 0.01% 1286
2019
Q1
$15.9M Buy
372,107
+6,573
+2% +$281K 0.01% 1259
2018
Q4
$16.4M Sell
365,534
-7,073
-2% -$317K 0.01% 1122
2018
Q3
$25.5M Sell
372,607
-24,023
-6% -$1.65M 0.02% 990
2018
Q2
$22.7M Sell
396,630
-64,437
-14% -$3.69M 0.02% 985
2018
Q1
$21.2M Sell
461,067
-101,796
-18% -$4.69M 0.02% 954
2017
Q4
$26M Sell
562,863
-128,122
-19% -$5.92M 0.02% 808
2017
Q3
$31.1M Sell
690,985
-107,008
-13% -$4.82M 0.03% 621
2017
Q2
$31.3M Buy
797,993
+27,421
+4% +$1.08M 0.03% 568
2017
Q1
$29.4M Buy
770,572
+76,646
+11% +$2.92M 0.03% 588
2016
Q4
$25.7M Buy
693,926
+261,028
+60% +$9.65M 0.03% 598
2016
Q3
$15M Buy
432,898
+137,190
+46% +$4.76M 0.02% 879
2016
Q2
$9.62M Buy
295,708
+14,790
+5% +$481K 0.01% 1095
2016
Q1
$8.07M Buy
280,918
+44,777
+19% +$1.29M 0.01% 1190
2015
Q4
$7.89M Buy
236,141
+41,120
+21% +$1.37M 0.01% 1181
2015
Q3
$5.55M Buy
195,021
+39,582
+25% +$1.13M 0.01% 1398
2015
Q2
$6.3M Buy
155,439
+90,582
+140% +$3.67M 0.01% 1394
2015
Q1
$3.19M Buy
64,857
+6,214
+11% +$306K ﹤0.01% 1788
2014
Q4
$2.67M Buy
+58,643
New +$2.67M ﹤0.01% 1844